Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

Clinical trial NCT05702931 · RECRUITING

Trial details

NCT number: NCT05702931
Sponsor: Rigshospitalet, Denmark
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperglycemia Renal Transplant Complication Primary Non-Function Diabetes

Start date: 2024-09-19
Primary completion: 2027-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.